logo
Select company
Select metric
$ -49.38MConsolidated Income
VS
Market
19
Sector
39
Industry
50
History
33
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

CARM

Company Name

CARISMA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARISMA THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CARM - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -49.38M
3/31/2025$ -50.77M
12/31/2024$ -60.48M
9/30/2024$ -63.8M
6/30/2024$ -72.5M
3/31/2024$ -81.22M
12/31/2023$ -86.88M
9/30/2023$ -73.5M
6/30/2023$ -31.64M
3/31/2023$ -43.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -40.94M.
  • Over the past 5 years, CARISMA THERAPEUTICS INC's average Cons. Inc. has been $ -43.05M.
  • The median Cons. Inc. for CARISMA THERAPEUTICS INC during this period was $ -46.55M
  • CARISMA THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ 54.37M.
  • The lowest Cons. Inc. recorded by CARISMA THERAPEUTICS INC in the same timeframe $ -119.47M

CARISMA THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
CSCIF : COSCIENS BIOPHARMA INC $ -18.84MBOLT : BOLT BIOTHERAPEUTICS INC $ -50.71MJAGX : JAGUAR HEALTH INC $ -41.41MTRAW : TRAWS PHARMA INC $ -17.82MCRIS : CURIS INC $ -38.92MMRKR : MARKER THERAPEUTICS INC $ -14.61MLGVN : LONGEVERON INC $ -18.54MCYCN : CYCLERION THERAPEUTICS INC $ -1.95MLYRA : LYRA THERAPEUTICS INC $ -38.84MBCAB : BIOATLA INC $ -59.52M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

CARM - Consolidated Income, Last 5 years

$ -119.47M

Minimum

Mar 31, 2021

$ 54.37M

Maximum

Mar 31, 2022

$ -43.05M

Average

$ -46.55M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M